Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?

2006661 citationsReview

Authors

Thomas Luke · Uniformed Services University of the Health Sciences

Edward M. Kilbane · Protein Potential (United States)

Jeffrey L. Jackson · Protein Potential (United States)

Stephen L. Hoffman · Uniformed Services University of the Health Sciences

Abstract

Patients with Spanish influenza pneumonia who received influenza-convalescent human blood products may have experienced a clinically important reduction in the risk for death. Convalescent human H5N1 plasma could be an effective, timely, and widely available treatment that should be studied in clinical trials.

Topics & Keywords

Influenza Virus Research Studies Respiratory viral infections research Neuroscience of respiration and sleep

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Internal Medicine

Volume 145, Issue 8, pp. 599-609

DOI: 10.7326/0003-4819-145-8-200610170-00139

Field-Weighted Citation Impact: 9.69